Answers are grounded in this paper and cite their sources.
Analysis reports unknown acceptance of routine SARS-CoV-2 surveillance testing in patients receiving dialysis, highlighting the need to evaluate nonmandatory screening.
Integrating routine SARS-CoV-2 testing in dialysis facilities may benefit patients receiving dialysis by mitigating risks of serious illness and reducing transmission. Patient acceptance of nonmandatory testing is unknown.
No takes yet. Share an insight, caveat, or question.
Montez‐Rath et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: